TSLP shapes the pathogenic responses of memory CD4+ T cells in eosinophilic esophagitis science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgades leadership team.
The battle for reasonable and market-driven prescription drug prices continues even as Medicare readies to negotiate prices for the top 10 most expensive drugs this fall.